Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Teva
Harvard Business School
Baxter
Daiichi Sankyo
Accenture
AstraZeneca
Mallinckrodt
Merck

Generated: April 23, 2018

DrugPatentWatch Database Preview

NANDROLONE PHENPROPIONATE Drug Profile

« Back to Dashboard

Which patents cover Nandrolone Phenpropionate, and when can generic versions of Nandrolone Phenpropionate launch?

Nandrolone Phenpropionate is a drug marketed by Watson Labs and is included in two NDAs.

The generic ingredient in NANDROLONE PHENPROPIONATE is nandrolone phenpropionate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone phenpropionate profile page.
Drug patent expirations by year for NANDROLONE PHENPROPIONATE
Synonyms for NANDROLONE PHENPROPIONATE
(17beta)-3-oxoestr-4-en-17-yl 3-phenylpropanoate
(1S,2R,10R,11S,14S,15S)-15-methyl-5-oxotetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-14-yl 3-phenylpropanoate
(1S,2R,10R,11S,14S,15S)-15-METHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-YL 3-PHENYLPROPANOATE
(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl 3-phenylpropanoate
[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] 3-phenylpropanoate
17-.beta.-hydroxyestr-4-en-3-one hydrocinnamate
17-(1-oxo-3-phenylpropoxy)estr-4-en-3-one (9CI)
17-beta-Hydroxy-estra-4-en-3-one, 17-phenylpropionate
17-beta-Hydroxyestr-4-en-3-one 17-(3-phenylpropionate)
17-beta-hydroxyestr-4-en-3-one hydrocinnamate
17-beta-Phenylpropionyloxy-4-estren-3-one
17.beta.-Phenylpropionyloxy-4-estrene-3-one
17b-hydroxyestr-4-en-3-one 17-(3-phenylpropionate)
17b-hydroxyestr-4-en-3-one17-
17beta-Hydroxyestr-4-en-3-one hydrocinnamate
17beta-Phenylpropionyloxy-4-estrene-3-one
19-Norandrostenolone phenylpropionate
19-Nortestosterone phenyl propionate
19-Nortestosterone phenylpropionate
19-Nortestosterone, hydrocinnamate
198N407
19Ntpp
3-Oxo-4-estren-17beta-yl-(3-phenylpropionat)
3-oxoestr-4-en-17beta-yl 3-phenylpropanoate
4-09-00-01758 (Beilstein Handbook Reference)
62-90-8
AC1L5HC1
AC1Q6P5U
Activin
Activine
AKOS015888240
Anabosan
Anticatabolin
BRN 3170861
C-21840
C08155
CAS-62-90-8
CC-32426
CHEBI:7468
CHEMBL1200412
CN0050
D00956
D0TB8C
DB00984
DSSTox_CID_3353
DSSTox_GSID_23353
DSSTox_RID_76989
DTXSID2023353
Dubol-100
Durabol
Durabolin
Durabolin-50
Duranox
EINECS 200-551-9
Equibolin
Estr-4-en-3-one, 17-(1-oxo-3-phenylpropoxy)-, (17beta)-
ESTR-4-EN-3-ONE, 17-beta-HYDROXY-, HYDROCINNAMATE
Estr-4-en-3-one, 17beta-hydroxy-, hydrocinnamate (8CI)
Estr-4-en-3-one, hydrocinnamate
Estr-4-en-3-one,17-(1-oxo-3-phenylpropoxy)-, (17b)-
Estr-4-ene-3-one, 17-beta-hydroxy-, 3-phenylpropionate
Fenobolin
Hybolin
KF7Z9K2T3W
Nadrolone phenylpropionate
Nandrobolic
Nandrolin
Nandrolon phenylpropionate
Nandrolone phenpropionate (USP)
Nandrolone phenpropionate [USP]
Nandrolone Phenylpionate
nandrolone phenylpropionate
Nandrolone phenylpropionate (JAN)
Nandrolonephenylpropionate
NCGC00159356-02
NCGC00274069-01
Nerobil
Nerobiolil
Nerobolil
Norandrol
Norandrolone phenyl propionate
Norandrolone phenylpropionate
Norandrostenolone phenylpropionate
Nortestosterone Furanpropionate
Nortestosterone phenylpropionate
NSC 23162
NSC-23162
NSC23162
NTPP
Phenobolin
PL000347
SC-16213
SCHEMBL8443
Sintabolin
SK 22271
Strabolene
Superanabolon
Tox21_113342
Tox21_113342_1
UNII-KF7Z9K2T3W
W-104946
ZINC3881613

US Patents and Regulatory Information for NANDROLONE PHENPROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs NANDROLONE PHENPROPIONATE nandrolone phenpropionate INJECTABLE;INJECTION 086386-001 Jun 17, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs NANDROLONE PHENPROPIONATE nandrolone phenpropionate INJECTABLE;INJECTION 087488-001 Jun 17, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Dow
UBS
Baxter
Julphar
Merck
Moodys
US Department of Justice
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.